Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer

Werner Schroth; Matthias Schwab

doi:10.3390/jpm12060917

Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer

J Pers Med. 2022 Jun 1;12(6):917. doi: 10.3390/jpm12060917.

Authors

Werner Schroth¹, Matthias Schwab^{1

2

3}

Affiliations

¹ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, University of Tuebingen, 70376 Tuebingen, German.
² Department of Clinical Pharmacology, University of Tübingen, 69120 Tuebingen, Germany.
³ Department of Biochemistry and Pharmacy, University of Tübingen, 69120 Tuebingen, Germany.

Abstract

The Special Issue "Genome Research and Personalized Medicine in Breast Cancer" presents studies on personalized medicine in breast cancer, originally with a focus on genomic treatment prediction at all stages of disease [...].

Publication types

Editorial

Grants and funding

W.S. and M.S. are supported by the Robert Bosch Stiftung, Stuttgart, Germany.